Skip to content

A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521947-19-00
Acronym
J2S-MC-GZML
Enrollment
26
Registered
2025-10-17
Start date
2025-11-19
Completion date
Unknown
Last updated
2025-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Hepatic Insufficiency

Interventions

None listed

Sponsors

Eli Lilly & Co.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Hungary, Slovakia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026